Abstract
Oncologic therapy is constantly evolving to improve patient outcomes, especially with regard to chemotherapy. The use of combination therapies and development and implementation of molecular targeted therapy lead to iatrogenic conditions that the radiologist must be aware of in interpreting studies of and caring for the oncologic patient. Knowledge of the chemotherapeutic agents and the imaging appearances of associated toxicities can impact patient management and decrease patient morbidity and mortality.
Original language | English (US) |
---|---|
Pages (from-to) | 1029-1040 |
Number of pages | 12 |
Journal | Radiologic Clinics of North America |
Volume | 52 |
Issue number | 5 |
DOIs | |
State | Published - 2014 |
Keywords
- Abdomen
- Complication
- Cytotoxic chemotherapy
- Pelvis
- Targeted therapy
- Toxicity
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging